NCT07001670

Brief Summary

This randomized controlled clinical trial aims to evaluate the effects of an 8-week tele-yoga intervention in individuals with lung cancer who have undergone lung resection surgery. The intervention group will receive supervised yoga sessions via online synchronous video conferencing, while the control group will continue with standard post-operative care. The primary outcome is exercise capacity (6-minute walk test), with secondary outcomes including pulmonary function, respiratory and peripheral muscle strength, physical activity level, dyspnea, fatigue, sleep quality, anxiety and depression, and quality of life. It is hypothesized that tele-yoga will improve physical and psychological recovery post-surgery and may serve as a feasible home-based pulmonary rehabilitation alternative.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Jun 2025Jul 2026

First Submitted

Initial submission to the registry

May 23, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 3, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

June 10, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2026

Last Updated

December 18, 2025

Status Verified

May 1, 2025

Enrollment Period

1 year

First QC Date

May 23, 2025

Last Update Submit

December 10, 2025

Conditions

Keywords

Exercise capacityPulmonary functionMuscle StrengthDyspneaFatigueAnxietyDepressionQuality of LifeExercise TherapyTelemedicineRehabilitation

Outcome Measures

Primary Outcomes (1)

  • The Six-Minute Walk Test (6MWT)

    Distance walked in six minutes will be recorded. Test will be conducted according to the guideline of American Thoracic Society. Functional exercise capacity will be evaluated with the six-minute walk test. Patients will be walked in a 30-meter-long corridor for 6 minutes and the maximum walking distance will be measured. Before and after the test, heart rate, blood pressure and O2 saturation will be measured with pulse oximetry, and dyspnea and fatigue levels will be determined according to the Modified Borg scale.

    Change from Baseline at 8 weeks

Secondary Outcomes (12)

  • Incremental Shuttle Walk Test (ISWT)

    Change from Baseline at 8 weeks

  • 6-Minute Pegboard and Ring Test (6PBRT)

    Change from Baseline at 8 weeks

  • Pulmonary Function Tests (PFT)

    Change from Baseline at 8 weeks

  • Respiratory Muscle Strength Test (MIP/MEP)

    Change from Baseline at 8 weeks

  • Peripheral Muscle Strength (Handgrip Strength Test)

    Change from Baseline at 8 weeks

  • +7 more secondary outcomes

Study Arms (2)

Tele-Yoga Group

EXPERIMENTAL

Participants in this arm will receive an 8-week supervised tele-yoga program delivered via real-time video conferencing.

Other: Tele-Yoga Training

Control Group

NO INTERVENTION

The control group will not receive any intervention.

Interventions

The Tele-yoga group will participate in real-time yoga sessions three times a week for eight weeks, including individual sessions for the first two weeks and small group sessions for the remaining six weeks, with all sessions supervised by a certified instructor. Each session will last approximately 45-60 minutes and include a 5-10 minute warm-up, 15-20 minutes of yoga postures, 15-20 minutes of yogic breathing exercises, and 5-10 minutes of relaxation and meditation.

Tele-Yoga Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 18 and 65 years,
  • Histologically confirmed diagnosis of Stage I-IIIA lung cancer according to the 9th edition of the AJCC Cancer Staging Manual,
  • Underwent lobectomy, pneumonectomy, segmentectomy, or wedge resection via thoracotomy or video-assisted thoracoscopic surgery (VATS),
  • An estimated life expectancy of ≥6 months,
  • Karnofsky Performance Status score greater than 80% at study entry,
  • Possession of the necessary equipment and access to a stable internet connection to enable participation in online interventions.

You may not qualify if:

  • History of receiving radiotherapy or chemotherapy prior to surgery,
  • Presence of severe dysfunction in vital organs such as the heart, brain, kidneys, or others,
  • Having any comorbid condition that contraindicates participation in an exercise training program,
  • Presence of serious postoperative complications,
  • Cognitive impairments that hinder effective communication,
  • Current participation in a structured and regular exercise program,
  • Missing three consecutive weeks of sessions or completing less than 75% of the prescribed exercises,
  • Voluntary withdrawal from the study by the participant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Thoracic Surgery, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Lung NeoplasmsDiseaseDyspneaFatigueAnxiety DisordersDepression

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Rengin Demir, Prof

    Istanbul University - Cerrahpasa

    PRINCIPAL INVESTIGATOR
  • Akif Turna, Prof

    Istanbul University - Cerrahpasa

    PRINCIPAL INVESTIGATOR
  • Sevde B Kara, PhD student

    Istanbul University - Cerrahpasa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessments will be performed by an investigator who is blinded to group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 23, 2025

First Posted

June 3, 2025

Study Start

June 10, 2025

Primary Completion (Estimated)

June 10, 2026

Study Completion (Estimated)

July 10, 2026

Last Updated

December 18, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations